Startup Spero Emerges With $3 Million, Backing From Roche

There seems to be a new scare every week in the world of antibiotics, because bacteria have the frustrating habit of evolving and becoming immune to current treatments. Atlas Venture’s latest seedling startup, Spero Therapeutics, believes it has a new type of answer for those tough-to-kill bugs—one that’s caught the attention, and potential dollars, of Roche.

Help employers find you! Check out all the jobs and post your resume.